002424.SZ
ST百灵
SZSE · Healthcare · C 制造业 · CN
CNY 4.55
+0.66%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.9B | 3.0B | 3.8B | 4.3B | 3.5B |
| Cost of Revenue | 1.6B | 1.6B | 1.6B | 1.9B | 1.4B |
| Gross Profit | 1.4B | 1.4B | 2.2B | 2.4B | 2.1B |
| Operating Expenses | |||||
| R&D Expense | 15.7M | 18.0M | 23.1M | 42.0M | 22.4M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 213.5M | 211.9M | 229.1M | 249.2M | 216.7M |
| Selling & Marketing Expense | 889.0M | 1.0B | 1.9B | 2.3B | 1.5B |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 1.2B | 1.3B | 2.2B | 2.7B | 1.9B |
| Cost and Expenses | 2.8B | 3.0B | 3.8B | 4.6B | 3.3B |
| Operating Income (EBIT) | 75.8M | 78.7M | 4.4M | (484.4M) | 155.6M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 40.3M | 40.5M | 66.9M | (493.1M) | 159.1M |
| Income Tax Expense | 140.4M | 143.6M | 30.1M | (80.6M) | 22.8M |
| Bottom Line | |||||
| Net Income | (100.3M) | (104.4M) | 33.6M | (414.5M) | 138.5M |
| Earnings from Cont. Ops | (100.1M) | (103.1M) | 36.8M | (412.5M) | 136.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (100.3M) | (104.4M) | 33.6M | (414.5M) | 138.5M |
| Per Share | |||||
| Basic EPS | (CN¥0.08) | (CN¥0.08) | CN¥0.02 | (CN¥0.30) | CN¥0.10 |
| Diluted EPS | (CN¥0.08) | (CN¥0.08) | CN¥0.02 | (CN¥0.30) | CN¥0.10 |
| Revenue Per Share | CN¥2.08 | CN¥2.34 | CN¥2.28 | CN¥3.09 | CN¥2.56 |
| Shares | |||||
| Basic Shares Outstanding | 1.4B | 1.3B | 1.7B | 1.4B | 1.4B |
| Diluted Shares Outstanding | 1.4B | 1.3B | 1.7B | 1.4B | 1.4B |
| Profitability Metrics | |||||
| EBITDA | — | 202.4M | 118.3M | (372.0M) | 266.3M |
| D&A | — | 123.7M | 114.0M | 112.4M | 110.7M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026